Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
Fabio Perversi, Cinzia Costa, Angelo Labate, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 18

Showing 18 citing articles:

AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit
Jeffrey M. Witkin, Daniel P. Radin, Sabhya Rana, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116302-116302
Closed Access | Times Cited: 8
Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today
Daniel P. Radin, Arnold S. Lippa, Sabhya Rana, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 248, pp. 173967-173967
Closed Access
[Efficacy and safety of perampanel add-on therapy in children with epilepsy of genetic etiology].
Jia-Qin Yi, Dan Sun
PubMed (2025) Vol. 27, Iss. 2, pp. 171-175
Closed Access
Effect of Age, Comedications, and CYP3A4/5 Polymorphisms on Perampanel Exposure in Chinese Pediatric Patients With Epilepsy
Huijuan Wang, Junyan Wang, Bin Lin, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 6, pp. 737-743
Closed Access | Times Cited: 4
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
Francesca Bosco, Lorenza Guarnieri, Vincenzo Rania, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12639-12639
Open Access | Times Cited: 9
Understanding the role of AMPA receptors in autism: insights from circuit and synapse dysfunction
Andrés Jiménez-Gómez, Megan X. Nguyen, Jason S. Gill
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study
Norman Delanty, Rajiv Mohanraj, Rohit Shankar, et al.
Epilepsy Research (2024) Vol. 202, pp. 107339-107339
Open Access | Times Cited: 3
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study
Angelo Pascarella, Lucia Manzo, Sara Gasparini, et al.
Journal of the Neurological Sciences (2024) Vol. 462, pp. 123106-123106
Closed Access | Times Cited: 3
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study
Angelo Pascarella, Sara Gasparini, Lucia Manzo, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122797-122797
Open Access | Times Cited: 4
The Cognitive and Behavioural Effects of Perampanel in Children with Neurodevelopmental Disorders: A Systematic Review
Giovanna Scorrano, Simona Lattanzi, Vincenzo Salpietro, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 372-372
Open Access | Times Cited: 1
Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population
Gianluca D’Onofrio, Roberta Roberti, Antonella Riva, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 3, pp. e00344-e00344
Open Access | Times Cited: 1
Brivaracetam use in clinical practice: a Delphi consensus on its role as first add-on therapy in focal epilepsy and beyond
Simona Lattanzi, Valentina Chiesa, Giancarlo Di Gennaro, et al.
Neurological Sciences (2024) Vol. 45, Iss. 9, pp. 4519-4527
Open Access | Times Cited: 1
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study
Adam Strzelczyk, Marta Maschio, Max C. Pensel, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 825-855
Open Access | Times Cited: 1
Harnessing the power of natural alkaloids: the emergent role in epilepsy therapy
Siyu Li, Xinyu Lin, Lijuan Duan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
A comprehensive assessment of palmatine as anticonvulsant agent – In vivo and in silico studies
Dorota Nieoczym, Marta Marszałek‐Grabska, Radosław Szalak, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116234-116234
Open Access
The Therapeutic Role of Perampanel in Treating Pediatric Patients With Dravet Syndrome: A Scoping Review
Anas S. Alyazidi, Osama Y. Muthaffar, Ahmed K. Bamaga, et al.
Cureus (2024)
Open Access
Brain tumor-related epilepsy: an overview on neuropsychological, behavioral, and quality of life issues and assessment methodology
Marta Maschio, Fabio Perversi, Andrea Maialetti
Frontiers in Neurology (2024) Vol. 15
Open Access
Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management
Robert H. Lipsky, Jeffrey M. Witkin, Hana Shafique, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access
Page 1

Scroll to top